Chinese Journal of Antituberculosis ›› 2020, Vol. 42 ›› Issue (2): 126-132.doi: 10.3969/j.issn.1000-6621.2020.02.009
• Original Articles • Previous Articles Next Articles
WANG Xue-di,JIANG Feng(),DAI Qian-lan,WANG Jing,WANG Dong-mei.
Received:
2019-11-09
Online:
2020-02-10
Published:
2020-02-19
Contact:
Feng JIANG
E-mail:jiangfengtcm@163.com
WANG Xue-di,JIANG Feng,DAI Qian-lan,WANG Jing,WANG Dong-mei.. Comparative analysis on drug-induced liver injury of the combination of traditional Chinese and Western medicine and single Western medicine in tuberculosis treatment (Literature review 2000-2019)[J]. Chinese Journal of Antituberculosis, 2020, 42(2): 126-132. doi: 10.3969/j.issn.1000-6621.2020.02.009
Add to citation manager EndNote|Ris|BibTeX
URL: http://www.zgflzz.cn/EN/10.3969/j.issn.1000-6621.2020.02.009
患者 类别 | 文献(年份) | 抗结核化疗方案 | 中医治法 | 中药 味数 | 方剂及组成 | 疗程 (月) | |
---|---|---|---|---|---|---|---|
初治 | 杨周剑等[ | 2H-R-E-Z/4H-R | 滋肺益肾、养阴清热、化痰止咳、杀虫止血 | 11 | 抗痨方:生地黄 9g、百合12g、麦冬9g、女贞子 20g、百部12g、黄芩12g、川贝母3g、桔梗15g、仙鹤草30g、陈皮 6g、生甘草6g | 6 | |
左根铜[ | 2H-R-Z-E/4H-R | 补肺益脾、滋阴益气 | 10 | 中医辨证论治(方剂不固定,药味取平均数) | 6 | ||
弓显凤等[ | H-R-Z-E | 养阴润肺、益气健脾、肺肾双补、杀虫 | 9 | 中医辨证论治(方剂不固定,药味取平均数) | 6 | ||
陈五海和巴清云[ | 2H-R-Z-E/4H-R | 补气滋阴、清除虚热 | 12 | 中医辨证论治(方剂不固定,药味取平均数) | 6 | ||
林萌[ | 2H-R-Z-E/4H-R | 杀虫抗痨、滋阴养血、润肺止咳 | 16 | 结核丸:生地黄、熟地黄、龙骨、紫石英、天冬、麦冬、阿胶、北沙参、熟大黄、龟甲、白芨、蜂蜡、牡蛎、川贝母、百部、鳖甲 | 6 | ||
复治 | 郭春辉等[ | 3H-R-Z-E-Rft-/5H-R-Rft | 滋阴润肺、益气降火 | 不详 | 中医辨证论治(方剂不固定,未列出全部药物) | 8 | |
王宝山[ | 3H-R-E-Z/6H-R-E | 活血止血、散瘀生新、祛痰止咳、健脾化湿 | 6 | 抗痨胶囊:百部、白芨、桑白皮、穿破石、矮地茶、五指毛桃等 | 9 | ||
耐药 | 王志远和李淑云[ | 3Pa-Rft-Lfx-Z-Am/18-Pa-Rft-Lfx-Z | 益气养阴、活血化瘀 | 14 | 补金片:白及、百部、鹿胶、红参、黄精、紫河车、茯苓、陈皮、蛤蚧、桃仁、当归、麦门冬、贝母、桔梗 | 3 | |
王业建和李超贤[ | 13Pa-Rft-Z-Am/10Z-Am | 滋阴润肺、健脾益气、活血化瘀 | 16 | 黄芪25g、党参15g、熟地黄15g、生地黄10g、麦冬15g、沙参20g、百合20g、百部10g、桔梗10g、白芍12g、柴胡6g、丹参15g、当归10g、甘草10g、桃仁 10g、瓜蒌15g | 10 | ||
陆霓虹等[ | 6Am-Lfx-Pa-Z-Pto/18Lfx-Pa-Z-Pto | 清热杀虫、滋阴润肺、益气健脾、补益肺肾 | 10 | 抗痨补肺汤:猫抓草、黄连、百部、白芨、沙参、麦冬、百合、生地、黄芪和甘草各 20g | 24 | ||
不详 | 杨月红[ | 2H-R-Z-E/4H-R | 滋阴润肺、滋阴清热、润肺止咳、益气养阴 | 9 | 补肺汤加减(方剂不固定,药味取平均数) | 8 | |
刘忠达等[ | 2H-R-Z-E/4H-R | 滋阴润肺、滋阴清热、润肺止咳、益气养阴 | 17 | 中医辨证论治(方剂不固定,药味取平均数) | 2 | ||
寿惠菁等[ | H-R-Z-E | 滋阴润肺、滋阴清热、润肺止咳、益气养阴 | 12 | 中医辨证论治(方剂不固定,药味取平均数) | 6 | ||
马喜明[ | H-R-Z-E | 攻坚逐饮、化气行水、标本兼治 | 4 | 己椒苈黄丸加减:汉防己15g、川椒目15g、葶苈子15g、制大黄9g | 1 | ||
朱旭霞[ | 2H3-R3-Z3-E3/4H3-R3 | 补肺、 益肾、 健脾和化痰杀虫 | 12 | 百合15g、百部20g、黄芪20g、党参15g、白术12g、茯苓15g、龟板20g、熟地黄20g、五味子20g、紫苑10g、皂角10g、猫爪草20g | 6 | ||
路振宇等[ | 2H-R-Z-E/4H-R或2H-R-Z-E/6H-R-E | 疏肝解郁、宽胸散结、和胃通腑、健脾助肺 | 17 | 百丹疏肝方:柴胡10g、香附8g、当归10g、白芍12g、丹参15g、郁金10g、茵陈10g、山楂15g、鸡内金10g、黄芪10g、白术10g、瓜蒌20g、厚朴15g、百合15g、沙参10g、秦艽5g、制大黄(后下)3g | 6 | ||
王洪元等[ | 抗结核药物加糖皮质激素 | 宜肺开郁降气、逐水活血 | 9 | 自拟逐饮汤:党参 12g、丹参 12g、川芎 12g、桃仁 10g、南沙参 12g、茯苓 12g、全当归 9g、泽泻 15g、车前子(包) 12g | 6 | ||
高敏[ | 2S-H-R/6H-R | 补中健脾、升阳活血 | 9 | 健脾活血中药:黄芪30g、人参20g、当归20g、枳实15g、白术15g、茯苓15g、地榆10g、大黄10g、甘草8g | 6 | ||
张亮等[ | H-R-Z-E | 祛痰逐水、杀虫破积 | 1 | 结核灵片(主要成分为狼毒) | 3 | ||
吕月秋[ | 抗结核药物加糖皮质激素 | 泄热利水、利水渗湿、活血止痛 | 9 | 自拟逐饮汤:泽泻15g,丹参、南沙参、党参、川芎、茯苓、车前子各12g,桃仁10g,全当归9g | 6 | ||
邱雪和郑定容[ | 3H-R-Z-E/6H-R-E | 养阴润肺、滋阴降火、益肺健脾、滋阴补阳 | 12 | 中医辨证论治(方剂不固定,药味取平均数) | 9 | ||
徐红艳等[ | H-R-Z-E/15H-R-E | 健脾利湿逐饮 | 12 | 葶苈大枣泻肺汤:葶苈子15g、大枣6枚、生薏米30g、白术15g、山药10g、鱼腥草30g、桑白皮15g、桔梗12g、白茅根30g、蒲公英15g、冬瓜仁30g、生甘草6g | 3 |
患者类别 | 文献(作者及出版年) | 试验组 | 对照组 | χ2值 | P值 |
---|---|---|---|---|---|
初治 | 杨周剑等[ | 17.07(7/41) | 37.50(15/40) | 4.270 | 0.039 |
左根铜[ | 16.67(6/36) | 25.00(9/36) | 0.758 | 0.384 | |
弓显凤等[ | 12.96(7/54) | 29.63(16/54) | 4.475 | 0.034 | |
陈五海和巴清云[ | 4.44(2/45) | 24.44(11/45) | 7.283 | 0.007 | |
林萌[ | 2.50(1/40) | 7.50(3/40) | 1.053 | 0.305 | |
合计 | 10.65(23/216) | 25.12(54/215) | 15.371 | <0.001 | |
复治 | 郭春辉等[ | 6.90(2/29) | 13.79(4/29) | 0.744 | 0.389 |
王宝山[ | 2.50(1/40) | 12.50(5/40) | 2.883 | 0.090 | |
合计 | 4.35(3/69) | 13.04(9/69) | 3.286 | 0.070 | |
耐药 | 王志远和李淑云[ | 25.71(9/35) | 74.30(26/35) | 16.514 | 0.000 |
王业建和李超贤[ | 8.33(5/60) | 6.45(4/62) | 0.158 | 0.691 | |
陆霓虹等[ | 6.25(5/80) | 20.00(12/60) | 6.076 | 0.014 | |
合计 | 10.86(19/175) | 26.75(42/157) | 13.940 | <0.001 | |
不详 | 杨月红[ | 23.00(23/100) | 38.00(38/100) | 5.307 | 0.021 |
刘忠达等[ | 23.00(46/200) | 38.50(77/200) | 11.282 | 0.001 | |
寿惠菁等[ | 15.00(6/40) | 37.50(15/40) | 5.230 | 0.022 | |
路振宇等[ | 14.81(8/54) | 38.89(21/54) | 7.967 | 0.005 | |
王洪元等[ | 10.94(7/64) | 9.38(6/64) | 0.086 | 0.770 | |
高敏[ | 10.00(4/40) | 27.50(11/40) | 4.021 | 0.045 | |
张亮等[ | 6.98(3/43) | 18.60(8/43) | 2.606 | 0.106 | |
吕月秋[ | 5.13(4/78) | 8.97(7/78) | 0.880 | 0.348 | |
邱雪和郑定容[ | 6.10(5/82) | 6.10(5/82) | 0.000 | 1.000 | |
徐红艳等[ | 4.76(2/42) | 28.57(12/42) | 8.571 | 0.003 | |
马喜明[ | 4.76(2/42) | 2.38(1/42) | 0.346 | 0.557 | |
朱旭霞[ | 2.00(1/50) | 5.00(2/40) | 0.621 | 0.431 | |
合计 | 13.29(111/835) | 24.61(203/825) | 34.626 | <0.001 |
[1] | 中华医学会结核病学分会. 抗结核药物性肝损伤诊治指南(2019年版). 中华结核和呼吸杂志, 2019,42(5):343-356. |
[2] | 曾萍, 叶品良, 杨捷 , 等. 耐药性肺结核的中医药治疗进展. 国医论坛, 2016,31(1):65-67. |
[3] | Shen T, Liu Y, Shang J , et al. Incidence and Etiology of Drug-Induced Liver Injury in Mainland China. Gastroenterology, 2019,156(8):2230-2241. |
[4] | 于乐成, 赖荣陶, 陈成伟 . 《2019年欧洲肝病学会临床实践指南:药物性肝损伤》精粹及评析. 临床肝胆病杂志, 2019,35(6):1242-1250. |
[5] | 禄保平, 彭勃 . 关于中医药防治抗结核药物后肝损伤的分析与思考. 中医药通报, 2005,4(2):49-52. |
[6] | 杨周剑, 吴国强, 陈晨 , 等. 抗痨方联合西药治疗阴虚火旺型初治继发性肺结核41例临床评价. 上海中医药杂志, 2014,48(5):56-59. |
[7] | 左根铜 . 中西医结合疗法治疗继发性肺结核的临床效果观察. 中国初级卫生保健, 2016,30(3):78-79,27. |
[8] | 弓显凤, 张熙祎, 张锦博 , 等. 中医辨证配合化疗治疗肺结核54例. 陕西中医, 2012,33(2):183-185. |
[9] | 陈五海, 巴清云 . 中医辨证治疗肺结核患者临床疗效及不良反应观察. 亚太传统医药, 2017,13(20):125-126. |
[10] | 林萌 . 中药结核丸辅助治疗初患涂阳肺结核的效果. 中国现代药物应用, 2019,13(7):146-147. |
[11] | 郭春辉, 辛瑞敏, 王晓瑞 , 等. 中西医结合治疗复治肺结核的临床观察. 医疗装备, 2016,29(10):3-4. |
[12] | 王宝山 . 中西医结合治疗复治涂阳肺结核病人疗效观察. 临床医药文献电子杂志, 2017,4(85):16698. |
[13] | 王志远, 李淑云 . 中西医结合治疗耐多药肺结核70例临床观察. 中国美容医学, 2011,20(3):405. |
[14] | 王业建, 李超贤 . 中西医结合治疗耐多药肺结核临床观察. 2011年中国防痨协会全国学术会议论文集, 2011: 259-260. |
[15] | 陆霓虹, 汪亚玲, 欧阳兵 , 等. 抗痨补肺汤联合化疗治疗耐多药肺结核随机平行对照研究. 实用中医内科杂志, 2015,29(10):98-100. |
[16] | 杨月红 . 中西医结合治疗肺结核的疗效及安全性评价. 中国医药指南, 2017,15(31):196-197. |
[17] | 刘忠达, 张尊敬, 李权 , 等. 中西医结合治疗肺结核临床研究. 中华中医药学刊, 2013,31(4):758-760. |
[18] | 寿惠菁, 賀颖, 刘磊 .中医辨证治疗对肺结核患者胃肠道反应率及肝功能改善作用. 中国地方病防治杂志, 2016, 31(8): 875,951. |
[19] | 路振宇, 党殿杰, 李军 , 等. 百丹疏肝方联合西医常规治疗肺结核合并肺部真菌感染的疗效观察. 河北中医, 2018,40(8):1205-1208. |
[20] | 王洪元, 白静, 金德华 . 中西医结合治疗结核性渗出性胸膜炎疗效观察. 现代中西医联合杂志, 2014,(27):2993-2995. |
[21] | 高敏 . 健脾活血中药联合抗结核化疗方案治疗肠结核疗效及对T淋巴细胞亚群、肠黏膜屏障功能的影响. 现代中西医联合杂志, 2018,27(3):308-311. |
[22] | 张亮, 梅月志, 李坤 , 等. 结核灵联合西医常规治疗颈部淋巴结结核的疗效观察. 罕少疾病杂志, 2019,26(3):40-42. |
[23] | 吕月秋 . 中西结合治疗结核性渗出性胸膜炎78例. 中国中医药现代远程教育, 2016,14(9):93-94. |
[24] | 邱雪, 郑定容 . 中西医结合联合支气管镜局部灌注治疗空洞型肺结核临床观察. 中外医学研究, 2017,15(4):17-20. |
[25] | 徐红艳, 甘昭平, 仵倩红 , 等. 中西医结合治疗84例结核性腹膜炎的疗效分析. 中国防痨杂志, 2018,40(10):1138-1140. |
[26] | 马喜明 . 中药己椒苈黄丸联合西医治疗结核性渗出性腹膜炎疗效观察. 现代中西医联合杂志, 2018,27(30):3395-3397. |
[27] | 朱旭霞 . 中西医结合治疗老年肺结核临床观察. 中国初级卫生保健, 2009,23(7):97-98. |
[28] | 唐神结, 高文 . 临床结核病学.北京:人民卫生出版社, 2011: 191-200. |
[29] | Saukkonen JJ, Cohn DL, Jasmer RM , et al. An official ATS Statement: hepatotoxicity of antituberculosis therapy. Am J Respir Crit Care Med, 2006,174(8):935-952. |
[30] | 刘旭东, 王炳元 . 我国药物性肝损害2003—2008年文献调查分析. 临床误诊误治, 2010,23(5):487-488. |
[31] | 田梦曦, 刘文兰 . 肝损伤中药治疗研究进展. 辽宁中医药大学学报, 2015,17(4):125-129. |
[32] | 王秀明, 王春华 . 大黄对扑热息痛致急性肝损伤的影响. 中国中西医联合消化杂志, 2011,19(5):311-314. |
[33] | 吴百灵 . 丹参对CCl4所致急性肝损伤保护作用的研究. 中医药学刊, 2002,20(3):363-381. |
[34] | 胡小玲, 汪晖, 吴基良 . 阿魏酸钠的抗肝损伤作用及其机制研究. 中国临床药理学与治疗学, 2004,9(1):74-76. |
[35] | 杨错, 刘玉兰, 张红梅 . 柴胡乳剂对急性化学性肝损伤的保护作用. 沈阳药科大学学报, 2006,23(2):105-108. |
[36] | 肖小河, 李秀惠, 朱云 , 等. 中草药相关肝损伤临床诊疗指南. 临床肝胆病杂志, 2016,32(5):835-843. |
[37] | 邓红星 . 中草药相关肝损伤文献分析及药物性肝损伤回顾性病例系列研究. 合肥:安徽医科大学, 2017. |
[1] | ZHOU Lin, LIU Er-yong, MENG Qing-lin, CHEN Ming-ting, ZHOU Xin-hua, GAO Wei-wei, LIN Ming-gui, XIE Ru-ming. Evaluation of the quality of pulmonary tuberculosis diagnosis after the implementation of the newly revised WS 288-2017 Diagnosis for pulmonary tuberculosis standards [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 910-915. |
[2] | LIANG Rui-yun, FANG Wei-jun, REN Hui-li, LI Hui-ru, ZHANG Hui. Study on CT manifestations of non-tuberculous mycobacterium pulmonary disease patients with and without diabetes mellitus [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 962-967. |
[3] | MA Ting-long, HAN Yi, CHENG Xu, LIU Zhi-dong. Clinical observation on treatment effectiveness of transdermal ultrasound-mediated drug delivery combined with oral anti-tuberculosis drug in patients with chest wall tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 968-972. |
[4] | ZHANG Li-juan, TAO Xiao, XIA Li-li, WEI Fen-fen, ZHENG Qi. Value of clinical pathway table of enhanced recovery cluster nursing in patients with spinal tuberculosis during perioperative period [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 981-986. |
[5] | LI Ai-fang, CUI Xiao-li, KANG Lei, LEI Jing, DANG Li-yun, YANG Han. Value of fluorescence PCR probe melting curve method in detecting resistance of Mycobacterium tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(9): 998-1001. |
[6] | ZHAO Tie-niu, JIANG Shuang-shuang, HUANG Li, HU Xue-mei. Comparative study of multislice spiral CT and color Doppler ultrasonography in the diagnosis of bone and joint tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 845-849. |
[7] | SUN Qing, HUANG Hai-rong, WANG Gui-rong. In vitro activities and drug resistance mechanisms of bedaquiline, clofazimine and delamanid against common pathogenic non-tuberculous mycobacteria [J]. Chinese Journal of Antituberculosis, 2020, 42(8): 880-884. |
[8] | FU Liang, DENG Guo-fang. Review on the progress of laboratory tests for activity judgment of pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 626-629. |
[9] | BAO Rui, LIU Xiao-yang, REN Peng, ZHANG Feng, LIANG Hai-yan, WANG Ru, FU Ling, GAN Di-shou. Analysis of surgical treatment characteristics in patients with spinal tuberculosis and HIV co-infection [J]. Chinese Journal of Antituberculosis, 2020, 42(6): 645-648. |
[10] | LI Bang-yin, PU Yu, HE Min, HE Lei, HUAN Ming-cang, CAI Yu-guo, LIU Lin, JIANG Xi. Clinical characteristics of HIV-positive spinal tuberculosis patients and effect analysis of strengthening perioperative management [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 449-453. |
[11] | ZHAO Ben-nan, LIU Da-feng, LIU Ya-ling, YANG Ming, LAN Li-juan, DU Qing. Clinical analysis of hypothyroidism after anti-tuberculosis treatment in patients with multidrug-resistant tuberculosis [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 465-471. |
[12] | ZHANG Jing, CHEN Xi, WANG Bin, FU Lei, LU Yu, CHEN Xiao-you. Establishment of modified propidium monoazide (PMAxx)-quantitative PCR assay and its application for identification of antituberculosis drug activity [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 472-480. |
[13] | ZHU Jian-kun, MENG Qian, JIN Feng. Exploration of the expression level of lipoxin A4 and its influence mechanism in process of tuberculous pleural fibrosis [J]. Chinese Journal of Antituberculosis, 2020, 42(5): 489-492. |
[14] | YANG Han,YANG Jing-fen,WU Hao,CUI Xiao-li,DANG Li-yun. Value of MicroDST test in detecting sensitivity of first-line anti-tuberculosis drugs [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 380-384. |
[15] | XIANG Hai-bin,LIANG Qiu-zhen,LI Xin-xia,SONG Xing-hua. Advances in the application of anti-tuberculosis nanoscale drug delivery system targeting macrophages [J]. Chinese Journal of Antituberculosis, 2020, 42(4): 398-403. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||